NEVRO CORP (32)

Browse by Contract Category

Contracts

Third Amendment to the Supply Agreement, effective as of November 1, 2021, by and between the Company and Greatbatch Ltd (Filed With SEC on May 4, 2022)
Nevro Corp. Non-Employee Director Compensation Program, as amended (Filed With SEC on February 23, 2022)
Offer Letter, dated as of May 15, 2020, by and between Roderick H. MacLeod and the Company (Filed With SEC on August 5, 2020)
Supplemental Indenture, dated April 6, 2020, by and between Nevro Corp. and Wilmington Trust, National Association, as Trustee (Filed With SEC on April 7, 2020)
Amendment to Supply Agreement, effective as of July 23, 2019, by and between the Company and Pro-Tech Design and Manufacturing, Inc (Filed With SEC on August 5, 2020)
Change in Control Severance Agreement, dated as of June 15, 2020, by and between Roderick H. MacLeod and the Company (Filed With SEC on August 5, 2020)
Second Amended and Restated Company Bonus Plan (Filed With SEC on August 5, 2020)
Assignment, Assumption and Amendment to Supply Agreement, effective as of December 31, 2019, by and between the Company, Greatbatch Ltd. and Centro de Construccion de... (Filed With SEC on May 5, 2020)
Form of Performance Stock Award Agreement and Performance Stock Award Grant Notice under the 2014 Equity Incentive Award Plan (Filed With SEC on May 5, 2020)
Letter Agreement, dated April 1, 2020, between Morgan Stanley & Co. International plc and Nevro Corp., regarding the Base Warrants (Filed With SEC on April 7, 2020)
Letter Agreement, dated April 2, 2020, between Morgan Stanley & Co. International plc and Nevro Corp., regarding the Additional Warrants (Filed With SEC on April 7, 2020)
Letter Agreement, dated April 2, 2020, between Morgan Stanley & Co. International plc and Nevro Corp., regarding the Additional Call Option Transaction (Filed With SEC on April 7, 2020)
Letter Agreement, dated April 2, 2020, between Goldman Sachs & Co. LLC and Nevro Corp., regarding the Additional Warrants (Filed With SEC on April 7, 2020)
Letter Agreement, dated April 2, 2020, between Goldman Sachs & Co. LLC and Nevro Corp., regarding the Additional Call Option Transaction (Filed With SEC on April 7, 2020)
Letter Agreement, dated April 1, 2020, between Morgan Stanley & Co. International plc and Nevro Corp., regarding the Base Call Option Transaction (Filed With SEC on April 7, 2020)
Letter Agreement, dated April 1, 2020, between Goldman Sachs & Co. LLC and Nevro Corp., regarding the Base Call Option Transaction (Filed With SEC on April 7, 2020)
Letter Agreement, dated April 1, 2020, between Goldman Sachs & Co. LLC and Nevro Corp., regarding the Base Warrants (Filed With SEC on April 7, 2020)
Underwriting Agreement, by and between Nevro Corp. and Morgan Stanley & Co. LLC, dated April 1, 2020, related to the Notes (Filed With SEC on April 7, 2020)
Underwriting Agreement, by and between Nevro Corp. and Morgan Stanley & Co. LLC, dated April 1, 2020, related to the Common Stock (Filed With SEC on April 7, 2020)
Transition and Separation Agreement, dated as of January 7, 2020, by and between the Company and Doug Alleavitch (Filed With SEC on February 25, 2020)
Change in Control Severance Agreement, dated as of September 16, 2019, by and between Niamh Pellegrini and the Company (Filed With SEC on February 25, 2020)
Description of Nevro Corp.s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 25, 2020)
Amended and Restated Change in Control Severance Agreement, effective July 22, 2019, by and between Patrick Schmitz and the Company (Filed With SEC on November 6, 2019)
Amended and Restated Change in Control Severance Agreement, effective July 22, 2019, by and between Kashif Rashid and the Company (Filed With SEC on November 6, 2019)
Amended and Restated Change in Control Severance Agreement, effective July 22, 2019, by and between Doug Alleavitch and the Company (Filed With SEC on November 6, 2019)
First Amendment to Supply Agreement, effective as of April 30, 2019, by and between the Company and Centro de Construccion de Cardioestimuladores del Uruguay S.A (Filed With SEC on August 8, 2019)
Nevro Corp. Non-Employee Director Compensation Program, as amended (Filed With SEC on August 8, 2019)
Amended and Restated Change in Control Severance Agreement, effective June 5, 2019, by and between Andrew Galligan and the Company (Filed With SEC on August 8, 2019)
Separation Agreement, dated March 18, 2019, by and between Rami Elghandour and the Company (Filed With SEC on May 9, 2019)
Employment Agreement by and between D. Keith Grossman and the Company, effective as of March 19, 2019 (Filed With SEC on May 9, 2019)
Settlement Agreement, dated as of March 19, 2019, among Nevro Corp. and Broadfin Capital, LLC and certain of its affiliates (Filed With SEC on March 20, 2019)
Nevro Corp. Non-Employee Director Compensation Program, as amended (Filed With SEC on February 21, 2019)